Comparison of Body Mass Index and Metabolic Score for Visceral Adiposity in Evaluation of Visceral Adiposity

Launched by GOZTEPE PROF DR SULEYMAN YALCIN CITY HOSPITAL · Dec 4, 2022

Keywords

ClinConnect Summary

This study is a single-center, observational and prospective study. Patients who underwent abdominal computed tomography (CT) covering the L3-L4 level in the last month for any reason and who did not have any of the following situations in the participants' CT reports: malignancy, pancreatitis, diseases requiring further investigation, chronic inflammatory diseases, and a pathology requiring hospitalization for more than 24 hours, will be invited to the study. Of the patients who consent to the study, gender, age, education level, current diseases, medications, and smoking status are questi...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having consented to the work
• • Having a computed tomography of the abdomen taken within the last month
• • Having a biochemistry analysis including lipid levels in the last three months
• • No weight loss in the last 3 months
• Exclusion Criteria:
• • Antihyperlipidemic medication usage
• • Presence of active malignancy
• • Having an anatomical structure that is not suitable for taking anthropometric measurements
• • The use medications that might affect metabolic values such as steroids
• • Chronic inflammatory diseases, acute infection and other lipodystrophic syndromes (HIV etc.)

Trial Officials